Get the Stockscreener App
5.81
55.31%
-7.19
Pre-market:
6.00
0.19
+3.27%
Nexentis Technologies Inc stock is traded at $5.81, with a volume of 2.07M.
It is down -55.31% in the last 24 hours and up +29.69% over the past month.
Nexentis Technologies Inc, is engaged in redefining mitochondrial drug discovery with help of its wholly owned biotechnology subsidiary, MitoCareX Bio focused on drug discovery company dedicated to developing first-in-class therapeutics for inflammatory metabolic diseases and cancer by targeting specific metabolic pathways. The company is also focused on sustainable operations in various industries such as solar projects, and oncology biotechnology.
See More
Previous Close:
$13.00
Open:
$6.62
24h Volume:
2.07M
Relative Volume:
1.79
Market Cap:
$4.24M
Revenue:
$2,000
Net Income/Loss:
$-12.72M
P/E Ratio:
-0.0809
EPS:
-71.8121
Net Cash Flow:
$-3.91M
1W Performance:
-0.17%
1M Performance:
+29.69%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$5.42
$6.90
1-Week Range:
$4.80
$23.80
52-Week Range:
$3.38
$23.80
Nexentis Technologies Inc Stock (NXTS) Company Profile
Name
Nexentis Technologies Inc
Sector
Industry
Phone
972544561349
Address
156 FIFTH AVENUE 10TH FLOOR, NEW YORK
Compare NXTS vs CTVA, NTR, CF, MOS, ICL
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NXTS
Nexentis Technologies Inc
|
5.81 | 4.24M | 2,000 | -12.72M | -3.91M | -71.81 |
CTVA
Corteva Inc
|
79.11 | 52.91B | 17.89B | 1.26B | 2.05B | 1.7029 |
NTR
Nutrien Ltd
|
61.54 | 29.54B | 27.83B | 2.42B | 2.21B | 4.9113 |
CF
Cf Industries Holdings Inc
|
102.17 | 15.70B | 7.41B | 2.12B | 1.62B | 11.13 |
MOS
Mosaic Company
|
21.25 | 6.75B | 12.05B | 575.40M | -534.60M | 1.6871 |
ICL
Icl Group Ltd
|
5.00 | 6.45B | 7.41B | 314.00M | 220.88M | 0.202 |
Nexentis Technologies Inc Stock (NXTS) Latest News
Nexentis Technologies Announces Registered Direct Offering and Warrants - The Globe and Mail
Nexentis Technologies Inc Offers 410,998 Shares At $7.056 Per ShareSEC Filing - TradingView
The market is filled with gapping stocks in Tuesday's session. - ChartMill
3 Penny Stocks to Watch Today, 6/23/2026 - TipRanks
Nexentis (NXTS) raises ~$2.9M via 410,998-share registered offering - Stock Titan
What's going on in today's pre-market session - ChartMill
Nexentis Technologies soars 156% before falling 46% after hours — here’s why NXTS stock is trending - MSN
Nexentis Technologies Soars 156% Before Falling 46% After Hours — Here’s Why NXTS Stock Is Trending - Benzinga
Dow Closes Up 144.62 Points at 51,709.32; Outdoor Holding Shares Fall After Q4 - scanx.trade
Nexentis Technologies Announces $2.9 Million Registered Direct Offering and Private Placement With Warrants - Minichart
Stocks to Watch: Primoris Services, Avis Budget, Nexentis Technologies - Moomoo
Nexentis Technologies Slides on Private Offerings - Moomoo
Nexentis Soars 156% on AI Drug Discovery Plans, Shares Fall After the Bell - TechStock²
Form 8K Nexentis Technologies Inc. For: 22 June By Investing.com - Investing.com Australia
What's going on in today's after hours session - ChartMill
Trending Stocks Today | Mangoceuticals Soars 41.16% Post-Market - Moomoo
Nexentis Technologies Raises ~$2.9 Million in Registered Direct Offering With 5-Year Warrants - TradingView
Nexentis (NXTS) lines up $2.9M registered direct and private placement - Stock Titan
symbol__ Stock Quote Price and Forecast - CNN
MitoCareX partners with Boltz on AI drug discovery effort - Investing.com UK
Crude Oil Falls Over 2%; Getty Images Shares Spike Higher - Benzinga
Nexentis Technologies Inc. (NXTS) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Trending Stocks Today | Nexentis Technologies Surges 275.87% - Moomoo
NXTS Stock Erupts As Traders Pile Into High-Volatility Move - StocksToTrade
Dow Jumps 200 Points; Outdoor Holding Shares Fall After Q4 Results - Benzinga
NXTS Stock Sparks Volatility As Traders Zero In On Cash Runway - timothysykes.com
NICE - Moomoo
MitoCareX partners with Boltz on AI drug discovery effort By Investing.com - Investing.com Australia
Nexentis taps Boltz AI to screen transporter targets for new drug leads - Stock Titan
Nexentis shares swing after subsidiary reaches drug discovery research milestone - MSN
NXTS News | NEXENTIS TECHNOLOGIES INC (NASDAQ:NXTS) - ChartMill
Nexentis stock choppy after subsidiary research milestone - Investing.com
Which stocks have an unusual volume on Wednesday? - ChartMill
Nexentis stock choppy after subsidiary research milestone By Investing.com - Investing.com Australia
Nexentis Shares Swing After Subsidiary Reaches Drug Discovery Research Milestone - Yahoo Finance
Nexentis subsidiary completes analysis of transport proteins By Investing.com - Investing.com Australia
Nexentis subsidiary completes analysis of transport proteins - Investing.com
Nexentis Technologies Inc. Subsidiary MitoCareX Bio Ltd. Completes Structural Analysis of SLC Transport Proteins to Enhance Drug Discovery Efforts - Quiver Quantitative
Nexentis Technologies (NXTS) sells 311,876 shares; concurrent warrants issued - Stock Titan
NXTS Q2 2025 Earnings: Loss Deepens as Pre‑Revenue Phase ContinuesGrowth Acceleration Report - newsline.com
Nexentis Technologies Announces New Equity Financing Agreements - TipRanks
Nexentis Technologies Raises $1.25 Million in Registered Direct Offering, Issues 5-Year Warrants - TradingView
Nexentis Technologies (NXTS) prices $1.25M stock and warrant offerings - Stock Titan
NXTS Q2 2025 Earnings: Loss Per Share of -$0.18 Amidst Limited Financial DisclosureRevenue Estimate Trend - newsline.com
Nexentis Technologies Inc. (NXTS) Surges 10.69% as Bullish Momentum BuildsVolatility Surface - newsline.com
NXTS Q2 2025 Earnings: Loss Per Share Widens but Stock Surges on Strategic ProgressHealthcare Earnings Report - newsline.com
NXTS Q2 2025 Earnings: Net Loss of -$0.18 Per Share Triggers Double-Digit Stock DeclineEPS Surprise History - newsline.com
Nexentis Technologies (NXTS) Earnings Date and Reports 2026 - MarketBeat
NXTS Q2 2025 Earnings: EPS Loss Narrows, Stock Surges on Operational ProgressHealthcare Earnings Report - The Legal Advocate
Nexentis Technologies (NXTS) Surges 5.1%: Key Levels and Volume Patterns Signal Potential BreakoutCalendar Spread Trade - The Legal Advocate
Nexentis Expands Credit Facility Under Amended Financing Agreement - TipRanks
Nexentis Technologies Inc Stock (NXTS) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.33%
0.02%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):